Кето-навигатор

54. Harris WS, Von Schacky C. The omega-3 index: a new risk factor for death from coronary heart disease? Prev Med. 2004 Jul; 39: 212–220.

55. von Schacky C, Harris WS. Cardiovascular benefits of omega-3 fatty acids. Cardiovasc Res. 2007 Jan 15; 73 (2): 310–315.

56. Siscovick DS, Raghunathan TE, King I, et al. Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA. 1995 Nov 1; 274 (17): 1363–1367.

57. Zampelas A, Roche H, Knapper JM, et al. Differences in postprandial lipaemic response between Northern and Southern Europeans. Atherosclerosis. 1998 Jul; 139 (1): 83–93.

58. Perez-Jimenez F, Lopez-Miranda J, Mata P. Protective effect of dietary monounsaturated fat on arteriosclerosis: beyond cholesterol. Atherosclerosis. 2002 Aug; 163 (2): 385–398.

59. Dubnov G, Berry EM. Omega-6/omega-3 fatty acid ratio: the Israeli paradox. World Rev Nutr Diet. 2003; 92: 81–91.

60. Yam D, Eliraz A, Berry EM. Diet and disease – the Israeli paradox: possible dangers of a high omega-6 polyunsaturated fatty acid diet. Isr J Med Sci. 1996 Nov; 32 (11): 1134–1143.

61. Renaud S, de Lorgeril M, Delaye J, et al. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr.1995 Jun 1; 61 (6): 1360s–1367s.

62. Covas MI, Nyyssonen K, Poulsen HE, et al. The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial. Ann Intern Med. 2006 Sep 5; 145 (5): 333–341.

63. Там же.

64. Is your olive oil fake? [Интернет]. Mercola.com. 2016 Dec 17 [открыто 4 июня 2018]. Доступно по адресу https://articles.mercola.com/sites/articles/archive/2016/12/17/fake-olive-oil.aspx.

Глава шестая

1. Borkman M, Storlien LH, Pan DA, et al. The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids. N Engl J Med. 1993 Jan 28; 328 (4): 238–244.

2. Vessby B, Gustafsson IB, Tengblad S, et al. Desaturation and elongation of Fatty acids and insulin action. Ann N Y Acad Sci.2002 Jun; 967: 183–195.

3. de Lorgeril M, Salen P, Defaye P, et al. Recent findings on the health effects of omega-3 fatty acids and statins, and their interactions: do statins inhibit omega-3? BMC Med. 2013; 11: 5.

4. Rise P, Ghezzi S, Priori I, et al. Differential modulation by simvastatin of the metabolic pathways in the n-9, n-6 and n-3 fatty acid series, in human monocytic and hepatocytic cell lines. Biochem Pharmacol. 2005 Apr 1; 69 (7): 1095–1100.

5. de Lorgeril M, Salen P, Guiraud A, et al. Lipid-lowering drugs and essential omega-6 and omega-3 fatty acids in patients with coronary heart disease. Nutr Metab Cardiovasc Dis. 2005 Feb; 15 (1): 36–41.

6. Nozue T, Yamamoto S, Tohyama S, et al. Comparison of effects of serum n-3 to n-6 polyunsaturated fatty acid ratios on coronary atherosclerosis in patients treated with pitavastatin or pravastatin undergoing percutaneous coronary intervention. Am J Cardiol.2013 Jun1; 111 (11): 1570–1575.

7. Harris JI, Hibbeln JR, Mackey RH, et al. Statin treatment alters serum n-3 and n-6 fatty acids in hypercholesterolemic patients. Prostaglandins Leukot Essent Fatty Acids. 2004 Oct; 71 (4): 263–269.

8. Kurisu S, Ishibashi K, Kato Y, et al. Effects of lipid-lowering therapy with strong statin on serum polyunsaturated fatty acid levels in patients with coronary artery disease. Heart Vessels. 2013 Jan; 28 (1): 34–38.

9. Nozue T, Yamamoto S, Tohyama S, et al. Effects of statins on serum n-3 to n-6 polyunsaturated fatty acid ratios in patients with coronary artery disease. Am J Cardiol. 2013 Jan 1; 111(1): 6–11.

10. Morris DH. Metabolism of alpha-linolenic acid. Flax Council of Canada. 2014.

11. Barcelo-Coblijn G, Murphy EJ. Alpha-linolenic acid and its conversion to longer chain n-3 fatty acids: benefits for human health and a role in maintaining tissue n-3 fatty acid levels. Prog Lipid Res. 2009 Nov; 48 (6): 355–374.

12. Al MD, Badart-Smook A, von Houwelingen AC, et al. Fat intake of women during normal pregnancy: relationship with maternal and neonatal essential fatty acid status. J Am Coll Nutr. 1996; 15 (1): 49–55.

13. Carlson SE, Werkman SH, Peeples JM, et al. Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur J Clin Nutr. 1994 Aug; 48 Suppl 2: S27–30.

14. Hornstra G. Essential fatty acids in mothers and their neonates. Am J Clin Nutr. 2000 May; 71 (5 Suppl): 1262s–1269s.

15. Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr. 2002 Oct; 88: 411–420.

16. Docosahexaenoic acid (DHA). Monograph. Altern Med Rev. 2009; 14 (4): 391–399.